Your browser doesn't support javascript.
loading
miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells.
Li, Mei; Li, Z Hubin; Song, Juanrong; Li, Xu; Zhai, Pengtao; Mu, Xudong; Qiu, Fakai; Yao, Le.
Afiliação
  • Li M; Department of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, China.
  • Li ZH; Department of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, China.
  • Song J; Department of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, China.
  • Li X; Department of Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, China.
  • Zhai P; Department of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, China.
  • Mu X; Department of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, China.
  • Qiu F; Department of Minimally Invasive Intervention, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, China.
  • Yao L; Department of Infectious Diseases, The First Hospital of Yulin, Yulin, Shaanxi, China. Email: sxsyaole@sina.com.
Cell J ; 24(3): 112-119, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35451580

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cell J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cell J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
...